Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ciforadenant. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

6 träffar

Bibliografisk träff 2024-06-06

Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as A2A Adenosine Receptor Antagonists: Exploring the Roles of Ribose at Adenosine Receptors.

Kim G, Jarhad DB, Lee G, Kim G, Hou X, Yu J, Lee CS, Warnick E, Gao ZG, Ahn SY, Kwak D, Park K, Lee SD, Park TU, Jung SY, Lee JH, Choi JR, Kim M, Kim D, Kim B, Jacobson KA, Jeong LS.

J Med Chem · research support, n.i.h., intramural; research support, non-u.s. gov't; research-article; journal article · DOI 10.1021/acs.jmedchem.4c01003

Bibliografisk träff 2023-03-23

Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A2A Receptor Antagonists for Cancer Immunotherapy.

Zhu C, Ze S, Zhou R, Yang X, Wang H, Chai X, Fang M, Liu M, Wang Y, Lu W, Xie Q.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.2c01860

Bibliografisk träff 2022-02-25

Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8H)-one Derivatives as Novel Potent Adenosine A2A Receptor Antagonists for Cancer Immunotherapy.

Yu F, Zhu C, Ze S, Wang H, Yang X, Liu M, Xie Q, Lu W, Wang Y.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.1c02199

Bibliografisk träff 2021-10-13

Adenosine receptor antagonists: Recent advances and therapeutic perspective.

Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2021.113907

Bibliografisk träff 2021-03-11

If small molecules immunotherapy comes, can the prime be far behind?

Zhang J, Zhang Y, Qu B, Yang H, Hu S, Dong X.

Eur J Med Chem · review; journal article · DOI 10.1016/j.ejmech.2021.113356

Bibliografisk träff 2020-07-30

Adenosine A2A Receptor Antagonists for Cancer Immunotherapy.

Yu F, Zhu C, Xie Q, Wang Y.

J Med Chem · research support, non-u.s. gov't; review; journal article · DOI 10.1021/acs.jmedchem.0c00237

Gå till forskningen.

Publikationer i urvalet

Structural Modification and Biological Evaluation of 2,8-Disubstituted Adenine and Its Nucleosides as A<sub>2A</sub> Adenosine Receptor Antagonists: Exploring the Roles of Ribose at Adenosine Receptors.

Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A<sub>2A</sub> Receptor Antagonists for Cancer Immunotherapy.

Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8<i>H</i>)-one Derivatives as Novel Potent Adenosine A<sub>2A</sub> Receptor Antagonists for Cancer Immunotherapy.

Adenosine receptor antagonists: Recent advances and therapeutic perspective.

If small molecules immunotherapy comes, can the prime be far behind?

Adenosine A<sub>2A</sub> Receptor Antagonists for Cancer Immunotherapy.